Birdwatch Note
2024-08-01 20:04:27 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Imane Khelif suffers from hyperandrogeny (higher than normal levels of androgens in the blood), a disease that results in a higher than normal testosterone level. She’s a female with above average T. She has lost to other women boxers. https://en.wikipedia.org/wiki/Imane_Khelif
Written by 7DAD358A42967BF1652185708D4BF23960656FD4124C4AE8B417F62BFFD53959
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819013548607152403
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819101911548940704
- noteId - 1819101911548940704
- participantId -
- noteAuthorParticipantId - 7DAD358A42967BF1652185708D4BF23960656FD4124C4AE8B417F62BFFD53959
- createdAtMillis - 1722542667650
- tweetId - 1819013548607152403
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Imane Khelif suffers from hyperandrogeny (higher than normal levels of androgens in the blood), a disease that results in a higher than normal testosterone level. She’s a female with above average T. She has lost to other women boxers. https://en.wikipedia.org/wiki/Imane_Khelif
Note Ratings
| rated at | rated by | |
| 2024-08-04 11:07:34 -0500 | Rating Details | |
| 2024-08-02 08:52:36 -0500 | Rating Details | |
| 2024-08-02 08:18:46 -0500 | Rating Details | |
| 2024-08-02 03:52:45 -0500 | Rating Details | |
| 2024-08-02 02:35:27 -0500 | Rating Details | |
| 2024-08-02 01:44:20 -0500 | Rating Details | |
| 2024-08-02 00:11:41 -0500 | Rating Details | |
| 2024-08-02 00:05:28 -0500 | Rating Details | |
| 2024-08-01 23:16:31 -0500 | Rating Details | |
| 2024-08-01 22:10:59 -0500 | Rating Details | |
| 2024-08-01 20:53:09 -0500 | Rating Details | |
| 2024-08-01 20:34:38 -0500 | Rating Details | |
| 2024-08-01 20:31:11 -0500 | Rating Details | |
| 2024-08-01 20:17:34 -0500 | Rating Details | |
| 2024-08-01 19:58:40 -0500 | Rating Details | |
| 2024-08-01 18:05:09 -0500 | Rating Details | |
| 2024-08-01 17:58:15 -0500 | Rating Details | |
| 2024-08-01 17:56:12 -0500 | Rating Details | |
| 2024-08-01 17:41:07 -0500 | Rating Details | |
| 2024-08-01 17:17:24 -0500 | Rating Details | |
| 2024-08-01 16:58:32 -0500 | Rating Details | |
| 2024-08-01 16:54:35 -0500 | Rating Details | |
| 2024-08-01 16:44:51 -0500 | Rating Details | |
| 2024-08-01 16:37:47 -0500 | Rating Details | |
| 2024-08-01 16:17:59 -0500 | Rating Details | |
| 2024-08-01 16:17:48 -0500 | Rating Details | |
| 2024-08-01 16:10:25 -0500 | Rating Details | |
| 2024-08-01 16:06:06 -0500 | Rating Details | |
| 2024-08-01 16:04:29 -0500 | Rating Details | |
| 2024-08-01 16:02:30 -0500 | Rating Details | |
| 2024-08-01 16:00:02 -0500 | Rating Details | |
| 2024-08-01 15:58:52 -0500 | Rating Details | |
| 2024-08-01 15:47:55 -0500 | Rating Details | |
| 2024-08-01 15:28:08 -0500 | Rating Details | |
| 2024-08-01 15:25:19 -0500 | Rating Details | |
| 2024-08-01 15:23:30 -0500 | Rating Details | |
| 2024-08-01 15:11:53 -0500 | Rating Details | |
| 2024-08-01 15:09:28 -0500 | Rating Details | |
| 2024-08-01 15:08:24 -0500 | Rating Details | |
| 2024-08-02 18:12:55 -0500 | Rating Details | |
| 2024-08-02 06:22:33 -0500 | Rating Details | |
| 2024-08-02 04:32:35 -0500 | Rating Details | |
| 2024-08-02 04:05:47 -0500 | Rating Details | |
| 2024-08-02 01:23:15 -0500 | Rating Details | |
| 2024-08-02 00:54:26 -0500 | Rating Details | |
| 2024-08-01 23:50:17 -0500 | Rating Details | |
| 2024-08-01 23:49:03 -0500 | Rating Details | |
| 2024-08-01 20:24:11 -0500 | Rating Details | |
| 2024-08-01 19:27:29 -0500 | Rating Details |